Health

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…

4 weeks ago

AscellaHealth Expands International Operations, Broadens Executive Leadership to Accelerate Global Market Access for Life Sciences

DUBLIN and BERWYN, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the…

4 weeks ago

BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion

DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioAro Inc., a biotechnology company at the forefront…

4 weeks ago

Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026

Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference…

4 weeks ago

Hassan Spine & Sports Medicine Rebrands as NefraHealth

New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing Central Jersey Practice OLD BRIDGE, N.J., Feb. 10,…

4 weeks ago

Ipsen – January 2026 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…

4 weeks ago

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors

PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS OF MINOR USE IN MAJOR SPECIES DESIGNATION FOR…

4 weeks ago

Carterra Launches Industrys First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discoveryEnables primary screening with high-resolution…

4 weeks ago

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis

Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create space for honest conversation among…

1 month ago

R1 Appoints Andy Brailo as Chief Commercial Officer

February 06, 2026 11:00 ET  | Source: R1 RCM Holdco Inc. CHICAGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- R1 (“R1”…

1 month ago